Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular

Tusamitamab ravtansine combined with SoC shows encouraging anti-tumour activity for patients with nonsquamous NSCLC

Dr Luis Paz-Ares - Hospital Universitario 12 de Octubre, Madrid, Spain
Tusamitamab ravtansine combined with SoC shows encouraging anti-tumour activity for patients with nonsquamous NSCLC ( Dr Luis Paz-Ares - Hospital Universitario 12 de Octubre, Madrid, Spain )
26 Apr 2023

CheckMate 649 biomarker analyses of NIVO + IPI vs chemo for patients with GC/GEJC/EAC

Dr Yelena Janjigian - Memorial Sloan Kettering Center, New York, USA
CheckMate 649 biomarker analyses of NIVO + IPI vs chemo for patients with GC/GEJC/EAC ( Dr Yelena Janjigian - Memorial Sloan Kettering Center, New York, USA )
26 Apr 2023

Initial results from a phase 1 dose escalation trial of E-602 shows efficacy in solid tumours

Dr Jason Luke - University of Pittsburgh, Pittsburgh, USA
Initial results from a phase 1 dose escalation trial of E-602 shows efficacy in solid tumours ( Dr Jason Luke - University of Pittsburgh, Pittsburgh, USA )
26 Apr 2023

VT3989 is safe and well tolerated in patients with advanced malignant mesothelioma and NF2m cancers

Dr Timothy Yap - The University of Texas MD Anderson Cancer Center, Houston, USA
VT3989 is safe and well tolerated in patients with advanced malignant mesothelioma and NF2m cancers ( Dr Timothy Yap - The University of Texas MD Anderson Cancer Center, Houston, USA )
25 Apr 2023

Combination of camonsertib plus PARPi shows clinical activity in DDR-aberrant tumours

Dr Timothy Yap - The University of Texas MD Anderson Cancer Center, Houston, USA
Combination of camonsertib plus PARPi shows clinical activity in DDR-aberrant tumours ( Dr Timothy Yap - The University of Texas MD Anderson Cancer Center, Houston, USA )
25 Apr 2023

Why tumour markers are not recommended as screening tests

Dr Frederic Ting - Riverside Medical Center, Bacolod, Philippines
Why tumour markers are not recommended as screening tests ( Dr Frederic Ting - Riverside Medical Center, Bacolod, Philippines )
20 Apr 2023

Latest treatments in oesophageal cancer

Dr Costas Bizekis - NYU Langone Perlmutter Cancer Center, New York, USA
Latest treatments in oesophageal cancer ( Dr Costas Bizekis - NYU Langone Perlmutter Cancer Center, New York, USA )
5 Apr 2023

Lung cancer screening and treatment in the Philippines

Dr Marcelo Severino Imasa - Lung Center of the Philippines, Manila, Philippines
Lung cancer screening and treatment in the Philippines ( Dr Marcelo Severino Imasa - Lung Center of the Philippines, Manila, Philippines )
4 Apr 2023

War in Ukraine: The logistical challenges of transferring medical materials

Dr Horia Vulpe, Dr Ruslan Baltaga
War in Ukraine: The logistical challenges of transferring medical materials ( Dr Horia Vulpe, Dr Ruslan Baltaga )
3 Apr 2023

Participation of Africa to global randomised controlled clinical trials

Dr Fidel Rubagumya - Rwanda Military Hospital, Kigali, Rwanda
Participation of Africa to global randomised controlled clinical trials ( Dr Fidel Rubagumya - Rwanda Military Hospital, Kigali, Rwanda )
8 Mar 2023

Choosing Wisely campaigns in Africa

Dr Fidel Rubagumya - Rwanda Military Hospital, Kigali, Rwanda
Choosing Wisely campaigns in Africa ( Dr Fidel Rubagumya - Rwanda Military Hospital, Kigali, Rwanda )
8 Mar 2023

Latest in PARP inhibitors and combination therapies for prostate cancer

Dr Dan George, Prof Noel Clarke, Dr Friederike Schlurmann and Prof Eleni Efstathiou
Latest in PARP inhibitors and combination therapies for prostate cancer ( Dr Dan George, Prof Noel Clarke, Dr Friederike Schlurmann and Prof Eleni Efstathiou )
19 Feb 2023

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation